v3.24.4
Summary of Significant Accounting Policies (Tables)
 9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Summary of Significant Accounting Policies [Abstract]    
Schedule of Fair Value Hierarchy of its Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table represents the Company’s fair value hierarchy of its financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2024 and December 31, 2023.
   September 30, 2024   December 31, 2023 
Description  Level 1   Level 2   Level 3   Level 1   Level 2   Level 3 
Short-term investments  $1,416,056   $
        -
   $
-
   $2,592,689   $
        -
   $
        -
 
Equity securities  $
-
   $
-
   $199,998   $
-
   $
-
   $
-
 
 The following table represents the Company’s fair value hierarchy of its financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2023 and 2022.
   December 31, 2023   December 31, 2022 
Description  Level 1   Level 2   Level 3   Level 1   Level 2   Level 3 
Short-term investments  $2,592,689   $
         -
   $
         -
   $
         -
   $
         -
   $
         -
 
Schedule of Computation of Diluted Shares Outstanding as they would have had an Anti-Dilutive Impact on the Company’s Net Loss For the three and nine months ended September 30, 2024 and 2023, the following common stock equivalents were excluded from the computation of diluted shares outstanding as they would have had an anti-dilutive impact on the Company’s net loss.
   September 30, 
   2024   2023 
Common stock equivalents:        
Warrants   2,666,096    11,245 
Stock options   64,084    38,333 
Total   2,730,180    49,578 
 The following were excluded from the computation of diluted shares outstanding as they would have had an anti-dilutive impact on the Company’s net loss.
   December 31, 
   2023   2022 
Common stock equivalents:        
Warrants   11,245    
       -
 
Stock options   38,333    
-
 
Total   49,578    
-
 
Schedule of Investment in Equity Securities, at Fair Value for the Periods The following table summarizes activity in the Company’s investment in equity securities, at fair value for the periods presented:
   Nine Months
Ended
September 30,		   Nine Months
Ended
September 30,		 
   2024   2023 
Balance, beginning of period  $
-
   $
        -
 
Additions   199,998    
-
 
Balance, end of period  $199,998   $
-